Brenham Dialysis in Brenham, Texas - Dialysis Center

Brenham Dialysis is a medicare approved dialysis facility center in Brenham, Texas and it has 12 dialysis stations. It is located in Washington county at 2815 Highway 36 South, Brenham, TX, 77833. You can reach out to the office of Brenham Dialysis at (979) 251-7287. This dialysis clinic is managed and/or owned by Davita. Brenham Dialysis has the following ownership type - Profit. It was first certified by medicare in February, 1992. The medicare id for this facility is 452641 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBrenham Dialysis
Location2815 Highway 36 South, Brenham, Texas
No. of Dialysis Stations 12
Medicare ID452641
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


2815 Highway 36 South, Brenham, Texas, 77833
(979) 251-7287

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Brenham Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1003879180
Organization NameBrenham Dialysis
Doing Business AsDva Renal Healthcare Inc
Address2815 Highway 36 S Brenham, Texas, 77833
Phone Number(979) 836-6391

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.52%67%
Patients who reported that nephrologists usually communicated and cared for them.17%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.31%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).56%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).28%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).16%14%

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.51%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.24%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.25%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).58%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).29%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).13%12%

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 78%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.22%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).73%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).25%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).2%12%

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data39
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL21

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center57
    Adult patient months included in Kt/V greater than or equal to 1.2498
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

    Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

    Conference to combat health care fraud

    With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

    Ethicon and Acclarent announce definitive merger agreement

    Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

    FDA approves Protein Sciences' Flublok to prevent seasonal influenza

    The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

    Read more Medical News

    › Verified 6 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center3
    Adult patient months included in Kt/V greater than or equal to 1.717
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

    Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

    Conference to combat health care fraud

    With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

    Ethicon and Acclarent announce definitive merger agreement

    Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

    FDA approves Protein Sciences' Flublok to prevent seasonal influenza

    The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

    Read more Medical News

    › Verified 6 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Brenham Dialysis with elevated calcium levels.

Patients with hypercalcemia61
Hypercalcemia patient months528
Patients with Serumphosphor67
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL17
Patients with Serumphosphor greater than 7 mg/dL12

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 68
Patient months included in arterial venous fistula and catheter summaries 495
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment80
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer2

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary55
Hospitalization Rate in facility160.9 (As Expected)
Hospitalization Rate: Upper Confidence Limit276.6
Hospitalization Rate: Lower Confidence Limit97.2

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Brenham Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility33 (As Expected)
Readmission Rate: Upper Confidence Limit45.9
Readmission Rate: Lower Confidence Limit22

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Brenham Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.55 (As Expected)
SIR: Upper Confidence Limit3.74
SIR: Lower Confidence Limit.49

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Brenham Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 50
Transfusion Rate in facility51.5 (As Expected)
Transfusion Rate: Upper Confidence Limit113.4
Transfusion Rate: Lower Confidence Limit25.7

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Brenham Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary207
Mortality Rate in facility10.3 (Better than Expected)
Mortality Rate: Upper Confidence Limit17.3
Mortality Rate: Lower Confidence Limit5.6

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago


Dialysis Facility in Brenham, TX

Brenham Dialysis
Location: 2815 Highway 36 South, Brenham, Texas, 77833
Phone: (979) 251-7287
Liberty Dialysis Brenham Llc
Location: 604 Medical Courts, Brenham, Texas, 77833
Phone: (979) 353-4440

News Archive

CNIC researchers discover high level of plasticity among cells in regenerating zebrafish heart

Some animals, including the zebrafish, have a high capacity to regenerate tissues, allowing them to recovery fully after cardiac injury. During this process, the heart muscle cells divide to replace the damaged tissue.

Conference to combat health care fraud

With estimates of annual losses as much as $230 billion and legitimate costs also skyrocketing, the US health care industry is now looking to better control the impact of fraud. And with the ever-growing amount of data involving health care claims, new automated fraud-fighting capabilities are absolutely required.

Ethicon and Acclarent announce definitive merger agreement

Ethicon, Inc., a Johnson & Johnson company and a worldwide leader in surgical care, and Acclarent, Inc., a privately held medical technology company dedicated to designing, developing and commercializing devices that address conditions affecting the ear, nose and throat (ENT), today announced a definitive merger agreement whereby Ethicon will acquire Acclarent in an all-cash transaction for approximately $785 million net of estimated cash on hand at time of closing.

FDA approves Protein Sciences' Flublok to prevent seasonal influenza

The US Food and Drug Administration has approved Protein Sciences Corporation's vaccine Flublok for the prevention of seasonal influenza in adults 18 to 49 years of age. Diamyd Medical holds about 8 percent of the shares in Protein Sciences Corporation.

Read more Medical News

› Verified 6 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.